Alimera Sciences Inc.

Ironwood Spruces for IPO Bid; Joins Parade with $172M Filing.
BIOWORLD Today; 11/24/2009; 1588 words; ...Managing Editor Ironwood Pharmaceuticals Inc. filed for an initial public offering...based Cumberland Pharmaceuticals Inc. raised $85 million in its August...enough to prompt ophthalmology firm Alimera Sciences Inc., of Atlanta, and stem cell company...

Research and Markets: Ophthalmic Pharmaceutical Drugs - A Global Market Perspective.
Business Wire; 11/18/2009; 607 words; ...AMERICA 14. REST OF WORLD EXHIBITS COMPANIES PROFILED * Akorn, Inc (USA) * Alcon Eye Care, Inc (USA) * Allergan, Inc. (USA) * Alimera Sciences, Inc (USA) * Bausch & Lomb, Inc (USA) * Genvec, Inc (USA) * Glaxosmithkline Plc (UK...

Ophthalmic Pharmaceutical Drugs - A Global Market Perspective.
M2 Presswire; 11/18/2009; 689 words; ...AMERICA 14. REST OF WORLD EXHIBITS COMPANIES PROFILED - Akorn, Inc (USA) - Alcon Eye Care, Inc (USA) - Allergan, Inc. (USA) - Alimera Sciences, Inc (USA) - Bausch & Lomb, Inc (USA) - Genvec, Inc (USA) - Glaxosmithkline Plc (UK...

Alimera Sciences, Inc.(IPO Sector)(Brief article)(Statistical data)
MondayMorning; 11/16/2009; 745 words; Elsewhere, Alimera Sciences, Inc. (Alpharetta GA) registered up to $80 million worth of common...those aimed at treating ocular diseases affecting the retina. Alimera's most advanced product candidate, Iluvien, is an intravitreal...

pSivida Corp. Reports Results for the First Quarter Ended September 30, 2009.
Business Wire; 11/12/2009; 1425 words; ...Company's amended collaboration agreement with Alimera Sciences, Inc. (Alimera), totaled $3.4 million for the three months...collaborative research and license agreement with Pfizer Inc. under which Pfizer may develop additional ophthalmic...